Results 211 to 220 of about 29,663 (265)

Therapeutic Outcome of Intralesional Immunotherapy in Cutaneous Warts Using the Mumps, Measles, and Rubella Vaccine: A Randomized, Placebo-controlled Trial.

, 2018
Guneet Awal, Simplepreet Kaur
openalex   +1 more source

Meningitis associated with measles-mumps-rubella vaccines.

Releve epidemiologique hebdomadaire, 1992
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Measles, Mumps, Rubella Vaccination and Autism

Annals of Internal Medicine, 2019
The hypothesized link between measles, mumps, rubella (MMR) vaccine and autism continues to cause concern and challenge vaccine uptake.
Anders, Hviid, Jørgen Vinsløv, Hansen, Morten, Frisch, Mads, Melbye   +3 more
  +10 more sources

Measles, mumps, rubella (MMR) vaccine

The Indian Journal of Pediatrics, 2003
MMR is a live attenuated vaccine. Indian children show almost 90% seroconversion against measles and rubella and 90% against mumps. Several adverse effects have been reported. Epidemiological studies do not support a causative link between MMR and autism, IBD or GBS. There is an association between the Urabe strain of mumps vaccine and viral meningitis.
A P, Dubey, S, Banerjee
openaire   +2 more sources

Allergic Reactions to Measles-Mumps-Rubella Vaccination

Pediatrics, 2001
Objective.Immunization of egg-allergic children against measles, mumps, and rubella (MMR) is often deferred or even denied, although the safety of this vaccination has been clearly shown. Moreover, the majority of severe allergic reactions have occurred in egg-tolerant vaccinees.
A, Patja, S, Mäkinen-Kiljunen, I, Davidkin, M, Paunio, H, Peltola   +4 more
openaire   +2 more sources

Measles–Mumps–Rubella Vaccine

2017
The measles–mumps–rubella (MMR) vaccine is currently the exclusive tool for the prevention of measles, mumps, and rubella in Europe. The description below of single measles, mumps, and rubella vaccines is given for historical reasons and for the characterization of their properties as components of the MMR vaccine.
Timo Vesikari, Vytautas Usonis
openaire   +1 more source

Neurologic Disorders After Measles-Mumps-Rubella Vaccination

Pediatrics, 2002
Objective. The possibility of adverse neurologic events has fueled much concern about the safety of measles-mumps-rubella (MMR) vaccinations. The available evidence concerning several of the postulated complications is controversial. The aim of this study was to assess whether an association prevails between MMR vaccination and encephalitis, aseptic ...
Annamari, Mäkelä, J Pekka, Nuorti, Heikki, Peltola   +2 more
openaire   +2 more sources

Combined Live Measles, Mumps, Rubella Vaccine

American Journal of Diseases of Children, 1971
A combined live attenuated measles, mumps, rubella vaccine was administered to 40 susceptible (seronegative) infants, 12 to 26 months of age. The antibody responses to the three viruses were excellent and the vaccine was well tolerated.
S, Krugman, G, Muriel, V J, Fontana
openaire   +2 more sources

Measles-Mumps-Rubella Vaccine and Autism

Pediatrics, 2003
To the Editor .— The recent article by Makela et al1 provides no meaningful data on any possible association between the measles-mumps-rubella (MMR) vaccine and autism. This manufacturer-supported study is biased toward a negative result. Using hospital admissions is designed to underestimate the …
openaire   +2 more sources